Tedia Company recently appointed Univar Solutions’ Ingredients and Specialties (I+S) division as the preferred distributor for its high-purity solvents and ultra-high purity (UHP) oligonucleotide and peptide synthesis (ONS) chemicals in the U.S. and Canada for pharmaceutical applications.
As the pharma industry evolves rapidly, the latest agreement enables I+S from Univar to expand and enhance its lineup of pharmaceutical ingredient solvents. This move benefits Univar customers, providing an advantage and the support needed to break new ground in pharmaceuticals, biologics, and innovative DNA technologies, the company reported.
“We are very excited about our partnership with Tedia as we extend our portfolio to include this broad range of high-purity and ultra-high purity solvents,” Aaron Lee, Univar global vice president of health and nutrition, said in a news release. “We are equipped with a portfolio of products that allows us to better serve our customers in pharmaceuticals, biologics, and DNA technologies with an enhanced level of purity, reliability, and the flexibility to deliver. Much like Ingredients + Specialties from Univar Solutions, Tedia has established itself as a leader in its field and is committed to innovation and excellence.
“Together, we are proud to innovate and redefine ingredient distribution as we deliver on the evolving needs of our customers in critical life science industries.”
The new portfolio includes key solvents at grades ranging from American Chemical Society (ACS) to UHP and beyond. Bringing together Tedia’s bulk distribution solutions and the global distribution network of I+S allows for scalable solutions optimized to meet high-volume and bulk demand with safety, consistency, and quality. Advancing science in a complex landscape, Tedia provides the runway for partners in pharmaceuticals, biologics, and DNA technologies to make innovative advancements that can change the landscape of our future.
Tedia also offers Tedia re:solv, a novel solvent recovery and repurification process that delivers on quality and value, and can contribute to advancing sustainability goals. Their advanced purification systems upgrade solvents and help meet the needs for critical applications in pharmaceuticals and other high-precision industries.
“This new alliance with Ingredients + Specialties from Univar Solutions will deliver streamlined, high-quality, cost-effective solutions for our existing customers and beyond," Tedia CEO Jim Mattey said. “This key partnership allows for enhanced distribution capacity, reduced lead times, enhanced product availability, the mitigation of supply chain risks, and the collaboration to meet critical production timelines for our customers. We are committed to advancing innovations in the UHP solvents space and their application in new treatments and therapies.
“Our collaboration has the power to drive breakthroughs and help shape the future of pharmaceutical and ONS advancements, impacting complex and emerging healthcare challenges for future generations.”